The DES Follow-Up Study investigates the long-term health consequences
associated with exposure to diethylstilbestrol (DES). Since 1992, the
National Cancer Institute, in collaboration with research
centers throughout the United States has been conducting the DES
Follow-Up Study of
more than 21,000 mothers, daughters, and sons.

Now in development: Winner and nominee in over 20
international film festival screenplay competitions and labs (including
the prestigious Hamptons Screenwriters Lab , Alfred P. Sloan Foundation and set in Boston, Massachusetts, WONDER DRUG is inspired by the true story of the drug DES (diethylstilbestrol),
seen as a medical miracle to help women with pregnancy issues and one
of the first cash cows for pharmaceutical companies ; but which was in
fact a toxic, carcinogenic drug and one of the biggest medical disasters
in history, affecting millions of people worldwide.

DES ACTION USA

DES Action USA is the only national nonprofit organization for those
who were exposed to DES.

DES Action USA provides education and advocacy for continued
research into the health concerns of DES Mothers, DES Daughters, DES
Sons and now DES Grandchildren.

DES Action USA also works on spreading awareness
about DES exposure to health care providers and the general
public. Unlike many consumer health organizations, DES Action USA
accepts no funding from drug companies. The support comes primarily from
members who understand the importance of DES in their lives and the
need for accurate information about it.